Break it Down: Lifeline to stroke and brain injury patients
EMVision’s completed further testing of its proof-of-concept First Responder device for traumatic brain and stroke injuries.
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
In this episode, Tylah Tully gives the skinny on EMVsion Medical Devices' (ASX:EMV) latest advancement of its 'First Responder' proof-of-concept device, throwing a potential life-line to traumatic brain injury and stroke patients.
Tune in to get the latest.
Originally published as Break it Down: Lifeline to stroke and brain injury patients
Silver bulls lead ASX explorers higher
Gold has been grabbing the headlines as it ventures above the US$3000/oz mark, but the quiet achievers have been silver stocks.
ASX up 1.2pc as tech shines, jobs dip
ASX rises +1pc, Nanosonics jumps after FDA approval, and Aussie job numbers dip, sparking rate cut hopes.
ASX rebounds, Nanosonics gets FDA nod
The ASX has bounced back after Wall Street’s surge. Meanwhile Nanosonics has soared on FDA approval, and Bitcoin is back above $86k while gold grabbed another personal best.